Page last updated: 2024-08-17

androstenedione and mestranol

androstenedione has been researched along with mestranol in 10 studies

Research

Studies (10)

TimeframeStudies, this research(%)All Research%
pre-19909 (90.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (10.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Brodsky, JL; Chiang, A; Chung, WJ; Denny, RA; Goeckeler-Fried, JL; Havasi, V; Hong, JS; Keeton, AB; Mazur, M; Piazza, GA; Plyler, ZE; Rasmussen, L; Rowe, SM; Sorscher, EJ; Weissman, AM; White, EL1
Andersen, RN; Givens, JR; Ragland, JB; Umstot, ES; Wiser, WL1
Chenault, CB; de la Peña, A; Dozier, TS; Goldzieher, JW; Kraemer, DC1
Andersen, RN; Givens, JR1
Andersen, RN; Fish, SA; Givens, JR; Umstot, ES; Wiser, WL1
Andersen, RN; Coleman, SA; Fish, SA; Givens, JR; Kerber, IJ; Wiser, WL1
Chapler, FK; Cruikshank, DP; Yannone, ME1
Lloyd, CW; Lobotsky, J; Puga, J; Pupkin, M; Weisz, J; Zanartu, J1
Andersen, RN; Fish, SA; Givens, JR; Wiser, WL1
Morris, CV; Wiebe, RH1

Other Studies

10 other study(ies) available for androstenedione and mestranol

ArticleYear
Increasing the Endoplasmic Reticulum Pool of the F508del Allele of the Cystic Fibrosis Transmembrane Conductance Regulator Leads to Greater Folding Correction by Small Molecule Therapeutics.
    PloS one, 2016, Volume: 11, Issue:10

    Topics: Alleles; Benzoates; Cells, Cultured; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Endoplasmic Reticulum; Furans; Gene Deletion; HEK293 Cells; HeLa Cells; High-Throughput Screening Assays; Humans; Hydroxamic Acids; Microscopy, Fluorescence; Protein Folding; Protein Structure, Tertiary; Pyrazoles; RNA, Messenger; Small Molecule Libraries; Ubiquitination; Vorinostat

2016
Adrenal function in hirsutism I. Diurnal change and response of plasma androstenedione, testosterone, 17-hydroxyprogesterone, cortisol, LH and FSH to dexamethasone and 1/2 unit of ACTH.
    The Journal of clinical endocrinology and metabolism, 1975, Volume: 40, Issue:6

    Topics: Adrenal Glands; Adrenocorticotropic Hormone; Adult; Androstenedione; Circadian Rhythm; Dexamethasone; Female; Follicle Stimulating Hormone; Hirsutism; Humans; Hydrocortisone; Hydroxyprogesterones; Luteinizing Hormone; Mestranol; Norethindrone; Testosterone

1975
Comparative studies of the ethynyl estrogens used in oral contraceptives: effects with and without progestational agents on plasma androstenedione, testosterone, and testosterone binding in humans, baboons, and beagles.
    Fertility and sterility, 1978, Volume: 29, Issue:4

    Topics: Androstenedione; Animals; Contraceptives, Oral; Dogs; Drug Interactions; Estradiol Congeners; Ethinyl Estradiol; Female; Haplorhini; Humans; Intrauterine Devices; Megestrol; Mestranol; Norethindrone; Norgestrel; Papio; Progesterone Congeners; Species Specificity; Testosterone; Therapeutic Equivalency

1978
Letter: Serum testosterone in the polycystic ovary syndrome.
    American journal of obstetrics and gynecology, 1975, Apr-15, Volume: 121, Issue:8

    Topics: Androstenedione; Female; Follicle Stimulating Hormone; Hirsutism; Humans; Luteinizing Hormone; Mestranol; Norethindrone; Ovarian Cysts; Ovary; Pituitary Gland; Testosterone

1975
The effectiveness of two oral contraceptives in suppressing plasma androstenedione, testosterone, LH, and FSH, and in stimulating plasma testosterone-binding capacity in hirsute women.
    American journal of obstetrics and gynecology, 1976, Feb-15, Volume: 124, Issue:4

    Topics: Adolescent; Adult; Androstenedione; Contraceptives, Oral; Contraceptives, Oral, Combined; Ethinyl Estradiol; Female; Follicle Stimulating Hormone; Hirsutism; Humans; Luteinizing Hormone; Mestranol; Norethindrone; Norgestrel; Protein Binding; Serum Globulins; Testosterone

1976
Remission of acanthosis nigricans associated with polycystic ovarian disease and a stromal luteoma.
    The Journal of clinical endocrinology and metabolism, 1974, Volume: 38, Issue:3

    Topics: 17-Ketosteroids; Acanthosis Nigricans; Adolescent; Adrenocorticotropic Hormone; Androstenedione; Chorionic Gonadotropin; Dexamethasone; Ethinyl Estradiol; Female; Humans; Luteinizing Hormone; Mestranol; Norethindrone; Ovarian Neoplasms; Polycystic Ovary Syndrome; Testosterone; Thecoma

1974
Arrhenoblastoma associated with adrenal androgenic hyperfunction.
    Obstetrics and gynecology, 1974, Volume: 43, Issue:4

    Topics: 17-Ketosteroids; Adrenocortical Hyperfunction; Adult; Amenorrhea; Androgens; Androstenedione; Contraceptives, Oral; Dehydroepiandrosterone; Depression, Chemical; Dexamethasone; Drug Combinations; Female; Humans; Hyperplasia; Infertility, Female; Mestranol; Norethynodrel; Ovarian Diseases; Ovarian Neoplasms; Sertoli-Leydig Cell Tumor; Testosterone

1974
Concentrations of unconjugated estrone, estradiol, androstenedione and testosterone in ovarian and peripheral venous plasma in women: the effects of steroid contraceptives.
    The Journal of clinical endocrinology and metabolism, 1973, Volume: 37, Issue:2

    Topics: 17-Ketosteroids; Adult; Androgens; Androstenedione; Chromatography, Paper; Contraceptives, Oral; Estradiol; Estrone; Ethynodiol Diacetate; Female; Humans; Medroxyprogesterone; Mestranol; Ovary; Progesterone; Protein Binding; Testosterone; Veins

1973
Dynamics of suppression and recovery of plasma FSH, LH, androstenedione and testosterone in polycystic ovarian disease using an oral contraceptive.
    The Journal of clinical endocrinology and metabolism, 1974, Volume: 38, Issue:5

    Topics: 17-Hydroxycorticosteroids; 17-Ketosteroids; Androstenedione; Female; Follicle Stimulating Hormone; Humans; Iodine Radioisotopes; Luteinizing Hormone; Mestranol; Norethindrone; Polycystic Ovary Syndrome; Radioimmunoassay; Testosterone; Time Factors

1974
Effect of an oral contraceptive on adrenal and ovarian androgenic steroids.
    Obstetrics and gynecology, 1984, Volume: 63, Issue:1

    Topics: Adolescent; Adult; Androgens; Androstenedione; Dehydroepiandrosterone; Drug Therapy, Combination; Female; Hirsutism; Humans; Mestranol; Norethindrone; Testosterone

1984